Predictions
First Majestic Silver Corp.
Start price
Target price
Perf. (%)
€8.15
11.01.23
11.01.23
-
11.01.24
11.01.24
-8.42%
21.01.23
21.01.23
Fortuna Silver Mines Inc.
Start price
Target price
Perf. (%)
€3.67
27.12.22
27.12.22
-
27.12.23
27.12.23
-5.36%
07.01.23
07.01.23
First Majestic Silver Corp.
Start price
Target price
Perf. (%)
€8.34
27.12.22
27.12.22
-
27.12.23
27.12.23
1.92%
07.01.23
07.01.23
Gran Tierra Energy Inc.
Start price
Target price
Perf. (%)
€10.48
27.06.22
27.06.22
-
27.06.23
27.06.23
-12.54%
01.01.23
01.01.23
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.58
17.11.22
17.11.22
-
17.11.23
17.11.23
-14.78%
26.12.22
26.12.22
First Majestic Silver Corp.
Start price
Target price
Perf. (%)
€8.41
12.12.22
12.12.22
-
12.12.23
12.12.23
-2.59%
24.12.22
24.12.22
Fortuna Silver Mines Inc.
Start price
Target price
Perf. (%)
€3.61
12.12.22
12.12.22
-
12.12.23
12.12.23
0.72%
24.12.22
24.12.22
Aptose Biosciences
Start price
Target price
Perf. (%)
€0.98
14.12.21
14.12.21
-
14.12.22
14.12.22
-39.08%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year
Fortuna Silver Mines Inc.
Start price
Target price
Perf. (%)
€3.47
28.11.22
28.11.22
-
28.11.23
28.11.23
5.39%
10.12.22
10.12.22
First Majestic Silver Corp.
Start price
Target price
Perf. (%)
€9.10
28.11.22
28.11.22
-
28.11.23
28.11.23
-6.58%
10.12.22
10.12.22
First Majestic Silver Corp.
Start price
Target price
Perf. (%)
€9.60
06.12.21
06.12.21
€12.00
06.12.22
06.12.22
-10.02%
06.12.22
06.12.22
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€4.85
01.12.21
01.12.21
-
01.12.22
01.12.22
-53.67%
02.12.22
02.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Fortuna Silver Mines Inc.
Start price
Target price
Perf. (%)
€3.42
14.11.22
14.11.22
-
14.11.23
14.11.23
1.49%
26.11.22
26.11.22
First Majestic Silver Corp.
Start price
Target price
Perf. (%)
€9.20
14.11.22
14.11.22
-
14.11.23
14.11.23
-2.72%
26.11.22
26.11.22
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.05
20.09.22
20.09.22
€1.80
20.09.23
20.09.23
36.59%
19.11.22
19.11.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.59
03.11.22
03.11.22
-
03.11.23
03.11.23
-6.74%
12.11.22
12.11.22
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.35
03.11.22
03.11.22
-
03.11.23
03.11.23
-5.40%
12.11.22
12.11.22
Fortuna Silver Mines Inc.
Start price
Target price
Perf. (%)
€2.93
01.11.22
01.11.22
-
01.11.23
01.11.23
13.19%
12.11.22
12.11.22
First Majestic Silver Corp.
Start price
Target price
Perf. (%)
€8.75
01.11.22
01.11.22
-
01.11.23
01.11.23
5.13%
12.11.22
12.11.22
Fortuna Silver Mines Inc.
Start price
Target price
Perf. (%)
€4.46
06.11.21
06.11.21
-
06.11.22
06.11.22
-34.65%
07.11.22
07.11.22
Top 10 in its market
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Capable Management